Design Therapeutics Inc
Ownership
Ownership Structure
Who owns Design Therapeutics Inc (DSGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 57.8% of the shares are freely tradable; institutional investors hold 62.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 10.43 | 6,526,476 | +0.0 | 06/30/2026 |
| Logos Global Management LP | 4.79 | 3,000,000 | +53.8 | 06/30/2026 |
| RA Capital Management, LLC | 4.75 | 2,972,973 | +103.4 | 03/31/2026 |
| Point72 Asset Management, L.P. | 4.35 | 2,722,754 | -49.3 | 03/31/2026 |
| Baker Bros Advisors LP | 4.13 | 2,585,978 | +15.8 | 03/31/2026 |
| BlackRock Inc | 3.41 | 2,133,764 | +0.8 | 03/31/2026 |
| Trails Edge Capital Partners, LP | 3.20 | 2,001,282 | +134.9 | 06/30/2026 |
| Driehaus Capital Management LLC | 2.79 | 1,744,987 | +47.9 | 03/31/2026 |
| Vivo Capital, LLC | 2.58 | 1,612,903 | +0.0 | 06/30/2026 |
| Almitas Capital LLC | 2.45 | 1,530,335 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.